Department of Infectious Diseases and Clinical Microbiology, Samsun Training and Research Hospital, Samsun, Turkey.
Department of Anesthesiology and Reanimation, Samsun Training and Research Hospital, Samsun, Turkey.
Turk J Med Sci. 2017 Apr 18;47(2):646-652. doi: 10.3906/sag-1511-29.
BACKGROUND/AIM: Central line-associated bloodstream infections (CLABSIs) are associated with substantial morbidity and mortality and the infection rates vary in a wide range1397645907(high: 62.5%; low: 20%) in developing countries. We aimed to investigate the characteristics and the risk factors for mortality in patients with CLABSIs in intensive care units (ICUs) and provide the relevant data.
The electronic medical records database and file records obtained through active surveillance by an infection control committee of a hospital were screened to identify patients with CLABSIs hospitalized from January 2008 through July 2013.
A total of 166 CLABSI episodes in 158 patients out of 17,553 on 38,562 catheter and 94,512 hospitalization days were evaluated. The infection developed in catheterized patients at a median of 14 days (range 2-88), and the highest infection rate with 13.4% (n = 20) was the femoral region among the places where the catheter was inserted. Of the patients catheterized, 54.4% survived whereas 45.6% died. In patients having Candida infection, the mortality was significantly higher. High APACHE II scores and Candida infections were found to be significant risk factors associated with mortality.
APACHE II scores and bloodstream infection with Candida species were the most powerful predictors of mortality. In ICU practice, health-care givers must consider the emerging role of Candida for both invasiveness and mortality.
背景/目的:中心静脉导管相关性血流感染(CLABSI)与较高的发病率和死亡率相关,且在发展中国家其感染率差异较大(高:62.5%;低:20%)。本研究旨在调查重症监护病房(ICU)中 CLABSI 患者的特征和死亡危险因素,并提供相关数据。
通过医院感染控制委员会的主动监测,筛选了 2008 年 1 月至 2013 年 7 月期间住院的 CLABSI 患者的电子病历数据库和档案记录。
共评估了 17553 例患者中的 158 例 166 例 CLABSI 发作,共使用了 38562 根导管和 94512 天。感染发生在置管患者中的中位数为 14 天(范围 2-88),感染率最高的部位是股部(13.4%,n=20)。在置管患者中,54.4%存活,45.6%死亡。在念珠菌感染者中,死亡率显著更高。较高的急性生理与慢性健康状况评分 II (APACHE II)评分和念珠菌感染是与死亡率相关的显著危险因素。
APACHE II 评分和念珠菌血流感染是死亡率的最强预测因素。在 ICU 实践中,医护人员必须考虑念珠菌在侵袭性和死亡率方面的新作用。